SCHEMBL4756932

SCHEMBL4756932

Cc1ccc(C(=O)Nc2ncc(S(=O)(=O)c3ccccc3)s2)cc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.59
KMT2A Q03164 9/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
MAPT P10636 2/20 0.51
POLB P06746 3/20 0.50
RXFP1 Q9HBX9 2/20 0.49
CRHBP P24387 2/20 0.48
CRHR2 Q13324 2/20 0.48
KDM4E B2RXH2 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.45
CCNE1 P24864 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757159 0.87 MEN1 (0.57) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL10114338 0.87 MEN1 (0.53) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL10114538 0.80 KMT2A (0.55) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL4757156 0.79 KMT2A (0.46) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL4757049 0.77 LMNA (0.51) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL4757111 0.75 MEN1 (0.47) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL4757209 0.74 MEN1 (0.46) MEN1KMT2ASMN1; SMN2MAPTPOLB
SCHEMBL4757983 0.74 KDR (0.61) MEN1KMT2ASMN1; SMN2MAPTNPC1
SCHEMBL5835870 0.73 CDK2 (0.67) MEN1KMT2ASMN1; SMN2POLBRXFP1
Hydrochloric Acid SCHEMBL29287796 0.72 LOXL2 (0.56) MEN1KMT2ASMN1; SMN2MAPTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC MEN1 4564/4885KMT2A 2303/4885SMN1; SMN2 3410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.